Deals
Deals dated after 30 September 2026 are still being collected.
Columns
1 of 1 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2026 | Neuphoria Therapeutics | – | Scancell Holdings | Acquisition | Financial adviser to Neuphoria Therapeutics (target) | Announced | – | Biotech+1 | Leerink Partners (buy-side)H.C. Wainwright & Co. (sell-side)Cooley (buy-side)Winston Taylor (sell-side) | Scancell Holdings acquisition of Neuphoria Therapeutics |